Sites of the Helmholtz Centre
The Sites of the Helmholtz Centre for Infection Research are distributed all over Germany. In addition to the main campus in Braunschweig, there are facilities in five other cities: Hamburg, Hanover, Saarbrücken, Würzburg and Greifswald.
The Helmholtz Institute for One Health is being established as a branch of HZI in Braunschweig and will be closely linked to the University of Greifswald, the University Medicine Greifswald and the Friedrich-Loeffler-Institut through a scientific cooperation agreement.
The new institute will follow a comprehensive, interdisciplinary approach to tackle health challenges arising from infectious diseases in line with the “One Health“ concept. The “One Health” Concept acknowledges that human health is tightly connected to the health of animals and an intact environment.
Globalization, climate change, enhanced mobility of humans, intensified livestock farming, as well as increasing urbanization and loss of natural habitats are key drivers for the onset and rapid spread of infections.Microbes move globally, breach species barriers and frequently develop multi-resistance. A global problem is also the lack of anti-infectives and vaccines. The current COVID-19 outbreak dramatically shows our still limited understanding of the origin and transmission of zoonotic infections and the urgent global need for more effective preventive and therapeutic measures to mitigate pandemic spread. The new institute will address this need and thus fill a critical gap.
Information on the local partners in Greifswald:
With its combination of population-oriented, epidemiological Community Medicine and state-of-the-art Molecular Medicine, the University Medicine Greifswald (UMG) has successfully developed a unique research profile in the past decades. The “Study of Health in Pomerania (SHIP)”, launched in 1997, is one of the most comprehensive longitudinal cohort studies, covering a vast array of phenotypic and genotypic characterization. The UMG is a partner site of the German Centre for Cardiovascular Research (DZHK) and the German Centre for Neurodegenerative Diseases (DZNE). With the newly established KAS+ project, the next step has been taken to make clinical information available for research. As infection and inflammation is one of UMG’s focus topics, the UMG offers access to clinical and health care settings to jointly generate much-needed knowledge and strategies to contain the persisting threat and health burden of infectious diseases.